Fragment-based covalent ligand discovery (vol 2, pg 354, 2021)

被引：1

作者：

Lu, Wenchao ^{[1
,2
]}

Kostic, Milka ^{[1
]}

Zhang, Tinghu ^{[1
,2
]}

Che, Jianwei ^{[1
,2
,3
]}

Patricelli, Matthew P. ^{[4
]}

Jones, Lyn H. ^{[3
]}

Chouchani, Edward T. ^{[1
,5
]}

Gray, Nathanael S. ^{[1
,2
]}

机构：

[1] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA

[2] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02215 USA

[3] Dana Farber Canc Inst, Ctr Prot Degradat, Boston, MA 02215 USA

[4] Vivid Therapeut, La Jolla, CA 92121 USA

[5] Harvard Med Sch, Dept Cell Biol, Boston, MA 02215 USA

来源：

RSC CHEMICAL BIOLOGY | 2021年 / 2卷 / 02期

关键词：

D O I：

10.1039/d1cb90008k

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Correction for 'Fragment-based covalent ligand discovery' by Wenchao Lu et al., RSC Chem. Biol., 2021, DOI: ; 10.1039/d0cb00222d.

引用

页码：670 / 671

页数：2

共 50 条

[41] Tethering: Fragment-based drug discovery
Erlanson, DA
Wells, JA
Braisted, AC
ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 2004, 33 : 199 - 223
[42] Fragment-Based Discovery of Irreversible Covalent Inhibitors of Cysteine Proteases Using Chlorofluoroacetamide Library
Miura, Chizuru
Shindo, Naoya
Okamoto, Kei
Kuwata, Keiko
Ojida, Akio
CHEMICAL & PHARMACEUTICAL BULLETIN, 2020, 68 (11) : 1074 - 1081
[43] Fragonomics: fragment-based drug discovery
Zartler, ER
Shapiro, MJ
CURRENT OPINION IN CHEMICAL BIOLOGY, 2005, 9 (04) : 366 - 370
[44] Fragment-Based Discovery of Indole Inhibitors of Matrix Metalloproteinase-13 (vol 54, pg 8174, 2011)
Taylor, Steven J.
Abeywardane, Asitha
Liang, Shuang
Muegge, Ingo
Padyana, Anil K.
Xiong, Zhaoming
Hill-Drzewi, Melissa
Farmer, Bennett
Li, Xiang
Collins, Brandon
Li, John Xiang
Heim-Riether, Alexander
Proudfoot, John
Zhang, Qiang
Goldberg, Daniel
Zuvela-Jelaska, Ljiljana
Zaher, Hani
Li, Jun
Farrow, Neil A.
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (15) : 6318 - 6318
[45] What makes a good fragment in fragment-based drug discovery?
Konteatis, Zenon
EXPERT OPINION ON DRUG DISCOVERY, 2021, 16 (07) : 723 - 726
[46] Covalent fragment-based ligand screening approaches for identification of novel ubiquitin proteasome system modulators
Rothweiler, Elisabeth M.
Brennan, Paul E.
Huber, Kilian V. M.
BIOLOGICAL CHEMISTRY, 2022, 403 (04) : 391 - 402
[47] Strategies and experiences in fragment-based drug discovery
Hubbard, Roderick E.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 510 - 510
[48] Fragment-based lead discovery grows up
Monya Baker
Nature Reviews Drug Discovery, 2013, 12 : 5 - 7
[49] Fragment-based approach to covalent inhibitors of catalytic cysteines
Kathman, Stefan
Xu, Ziyang
Statsyuk, Alexander
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
[50] A rule of three for fragment-based lead discovery?
Congreve, M
Carr, R
Murray, C
Jhoti, H
DRUG DISCOVERY TODAY, 2003, 8 (19) : 876 - 877

← 1 2 3 4 5 →